Diabetes and Diabetes Technology

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 22 | ESPEYB25

Yearbook of Paediatric Endocrinology 2025

13. Global Health for the Paediatric Endocrinologist

Previous section
Newborn Screening

Table of contents

Next section
Innovations in Global Health Care and Education

ey0022.13-11 | Diabetes and Diabetes Technology

13.11. Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013-22): a longitudinal analysis of data from paediatric diabetes registries

ey0022.13-12 | Diabetes and Diabetes Technology

13.12. Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: a randomised controlled trial

ey0022.13-13 | Diabetes and Diabetes Technology

13.13. Human vs analogue insulin for youth with type 1 diabetes in low-resource settings (human-1): protocol for a randomised controlled trial

ey0022.13-14 | Diabetes and Diabetes Technology

13.14. Pediatric type 1 diabetes care in Indonesia: a review of current challenges and practice

ey0022.13-15 | Diabetes and Diabetes Technology

13.15. Estimating the total incidence of type 1 diabetes in children and adolescents aged 0-19 years from 1990 to 2050: a global simulation-based analysis

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology